Bruker Shares Drop 12 Percent | GenomeWeb

Shares in Bruker BioSciences declined 12 percent for the five-day trading period ended Tuesday. The firm's stock dropped steadily from closing at $5.43 last Wednesday to $4.75 at the close of trading on Tuesday, with trading volume unusually high over the last few days. The only news from the firm was a molecular diagnostics alliance announced on Tuesday (see Briefs).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.